| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Apr | Jun » | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 | |||
May 9th, 2012 tmccoy
by: Stephanie Herschaft, Esq. Dabigatran (Pradaxa(R)) is the first oral thrombin/Xa inhibitor on the market in the United States. This drug, after having been cleared for use by the FDA, has been commercially available since November 2010. The medication is prescribed to patients to prevent thromboembolic complications that are a result of atrial fibrillation. Though [...]
May 9th, 2012 tmccoy
by: William Dubanevich, Esq. The explosion of a natural gas pipeline in the San Francisco suburb of San Bruno has caused the federal government to crack down on the America’s energy companies. The explosion occurred in September of 2010, killing eight people and injuring many more, while doing severe damage to 38 homes. The National [...]
May 9th, 2012 tmccoy
by: Jonathan Macri, Esq. Another popular weight-loss supplement has serious negative implications for the health of its users, the FDA has just warned. DMAA, which is an amphetamine-like substance, is very similar in its effects to ephedra, which was banned by the FDA back in 2004 after it was shown to cause a number of [...]
May 9th, 2012 tmccoy
by: Michael Werner, Esq. Bipartisan Senators Grassley and Baucus of the Senate Finance Committee are spearheading a government investigation into possible financial ties between prescription painkiller manufacturers and pain experts, patient advocacy groups and organizations that advise physicians how to prescribe specific drugs. The chief inquiry is whether the usage and safety information provided to [...]
